PARP inhibitors as first-line maintenance therapy in ovarian cancer: recommendations from an expert panel from Brazil by Aknar FC Calabrich, Daniele Xavier Assad, Graziela Dal-Molin, Andreia C Melo, Angelica Nogueira-Rodrigues, Karime Kalil, Andrea PG Guimarães, Michelle Samora Almeida, Carla Rameri de Azevedo, Daniela de Freitas, Alessandra Menezes Morelle, Ana Carolina Leite, Marcela Crosara, João Soares Nunes, Poliana Signorini, Eduardo Cronemberger, Rachel Cossetti, Rodrigo Guindalini, Eduardo Paulino, Fernando C Maluf

Get full text

Germline Genetic Testing in Breast Cancer: Utilization and Disparities in a Middle-Income Country by Alessandra Borba Anton de Souza, Carlos Barrios, Rafaela Gomes de Jesus, Tomas Reinert, Juliana Giacomazzi, Daniela D. Rosa, Eduardo Cronemberger, Gustavo Werutsky, José Bines, Geraldo Silva Queiroz, Vladmir Cordeiro de Lima, Ruffo Freitas-Junior, José d'Oliveira Couto Filho, Karla Emerenciano, Heloisa Resende, Susanne Crocamo, Brigitte Van Eyll, Yeni Neron, Vanessa Dybal, Nicolas Silva Lazaretti, Rita de Cassia Costamilan, Diocesio Alves Pinto de Andrade, Clarissa Mathias, Giovana Zerwes Vacaro, Giuliano Borges, Alessandra Menezes Morelle, Carlos Alberto Sampaio Filho, Max Mano, Martina Lichtenfels, Sergio D. Simon, Andre P. Fay

Get full text